| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.8M | +295.0% | +139.1% |
| Cost of Revenue | $4.0M | +182.4% | +73.3% |
| Gross Profit | $825K | +525.3% | +386.5% |
| R&D Expense | $404K | -48.1% | -81.7% |
| SG&A Expense | $6.0M | +29.2% | +18.5% |
| Operating Income | -$6.0M | -3.6% | +22.2% |
| Pre-tax Income | -$5.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $845K | +45.2% | -62.8% |
| Accounts Receivable | $2.4M | +35.3% | +359.0% |
| Inventory | $8.2M | +47.1% | +3.0% |
| Current Assets | $17.4M | +16.2% | +69.6% |
| Total Assets | $85.4M | -0.9% | +126.3% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$8.2M | — | — |
| Investing Cash Flow | -$53.5M | — | — |
| Financing Cash Flow | $62.2M | — | — |
| -140.0% |
| +26.7% |
| Income Tax | $0 | — | — |
| Net Income | -$5.2M | -140.0% | +26.7% |
| EPS (Basic) | -$3.11 | -46.0% | -103.3% |
| EPS (Diluted) | -$3.11 | -46.0% | -103.3% |
| $30.8M |
| +38.7% |
| +16.0% |
| Long-term Debt | $46.4M | -15.8% | +229.8% |
| Total Liabilities | $68.0M | -2.8% | +112.7% |
| Stockholders' Equity | $14.9M | -8.7% | +156.5% |